Symbols / WGRX $0.11 +4.53% Wellgistics Health, Inc.

Healthcare • Pharmaceutical Retailers • United States • NCM
WGRX Chart
About

Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes branded and generic pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Pharmaceutical Retailers Market Cap 11.13M
Enterprise Value 35.19M Income -101.27M Sales 23.34M
Book/sh -0.12 Cash/sh 42571.00 Dividend Yield —
Payout 0.00% Employees — IPO —
P/E — Forward P/E — PEG —
P/S 0.48 P/B -0.86 P/C —
EV/EBITDA -0.45 EV/Sales 1.51 Quick Ratio 0.04
Current Ratio 0.10 Debt/Eq — LT Debt/Eq —
EPS (ttm) -1.43 EPS next Y — EPS Growth —
Revenue Growth -86.50% Earnings — ROA -115.61%
ROE — ROIC — Gross Margin -27.54%
Oper. Margin -7.66% Profit Margin 0.00% Shs Outstand 104.87M
Shs Float 51.11M Short Float 9.85% Short Ratio 1.20
Short Interest — 52W High 7.04 52W Low 0.10
Beta — Avg Volume 2.72M Volume 478.04K
Target Price — Recom None Prev Close $0.10
Price $0.11 Change 4.53%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.11
Latest analyst target
3. DCF / Fair value
$1.31
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.11
Low
—
High
—
Mean
—
News
RSS: Latest WGRX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-07-02 PETERSON MICHAEL L Director — 200,000 $0.90 $180,000
2025-03-21 SHANAHAN REBECCA M Director — 200,000 $0.00 $0
2025-03-21 SYED SAJID Director — 200,000 $0.00 $0
2025-03-21 PATEL PRASHANT Officer and Director — 4,082,247 $0.00 $0
2025-03-21 AJJARAPU SURENDRA K Director — 4,082,247 $0.00 $0
2025-03-21 ANDERSON DONALD WILLIAM Director — 200,000 $0.00 $0
2025-03-21 PIRANI SHAFAAT Officer — 35,000 $0.00 $0
2025-03-21 NORTON BRIAN Chief Executive Officer — 9,000,000 $0.00 $0
2025-03-21 PANCHAL NIKUL Officer — 90,000 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
23.34
+28.73%
18.13
0.00
-100.00%
32.78
Operating Revenue
23.34
+28.73%
18.13
0.00
-100.00%
32.78
Cost Of Revenue
29.76
+81.92%
16.36
0.00
-100.00%
27.03
Reconciled Cost Of Revenue
29.76
+81.92%
16.36
0.00
-100.00%
27.03
Gross Profit
-6.43
-463.63%
1.77
0.00
-100.00%
5.75
Operating Expense
74.77
+844.95%
7.91
+174.68%
2.88
-68.59%
9.17
Research And Development
—
—
0.00
-73.21%
0.00
Selling General And Administration
71.56
+952.66%
6.80
+135.98%
2.88
-59.33%
7.08
Selling And Marketing Expense
1.22
0.00
—
—
General And Administrative Expense
70.33
+934.64%
6.80
+135.98%
2.88
-59.33%
7.08
Other Gand A
70.33
+934.64%
6.80
+135.98%
2.88
-59.33%
7.08
Total Expenses
104.53
+330.64%
24.27
+742.67%
2.88
-92.04%
36.20
Operating Income
-81.19
-1221.29%
-6.15
-113.33%
-2.88
+15.84%
-3.42
Total Operating Income As Reported
-93.75
-1425.58%
-6.15
-113.33%
-2.88
+15.84%
-3.42
EBITDA
-93.48
-1803.91%
-4.91
-70.45%
-2.88
-680.58%
-0.37
Normalized EBITDA
-77.94
-1487.38%
-4.91
-70.45%
-2.88
-31.71%
-2.19
Reconciled Depreciation
3.21
+188.07%
1.11
0.00
-100.00%
2.09
EBIT
-96.69
-1504.96%
-6.02
-109.15%
-2.88
-17.26%
-2.46
Total Unusual Items
-15.54
0.00
—
1.82
Total Unusual Items Excluding Goodwill
-15.54
0.00
—
1.82
Special Income Charges
-15.54
0.00
—
1.82
Other Special Charges
2.99
—
—
-1.82
Impairment Of Capital Assets
12.55
0.00
—
—
Net Income
-101.27
-1377.12%
-6.86
-136.77%
-2.90
-5.54%
-2.74
Pretax Income
-101.27
-1377.12%
-6.86
-136.77%
-2.90
-5.54%
-2.74
Net Non Operating Interest Income Expense
-4.58
-450.78%
-0.83
-5413.34%
-0.02
+94.75%
-0.29
Interest Expense Non Operating
4.58
+450.78%
0.83
+5413.34%
0.02
-94.75%
0.29
Net Interest Income
-4.58
-450.78%
-0.83
-5413.34%
-0.02
+94.75%
-0.29
Interest Expense
4.58
+450.78%
0.83
+5413.34%
0.02
-94.75%
0.29
Other Income Expense
-15.50
-12976.76%
0.12
+22.66%
0.10
-89.84%
0.97
Other Non Operating Income Expenses
0.04
-65.07%
0.12
-33.30%
0.18
+121.18%
-0.85
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-101.27
-1377.12%
-6.86
-136.77%
-2.90
-5.54%
-2.74
Net Income From Continuing Operation Net Minority Interest
-101.27
-1377.12%
-6.86
-136.77%
-2.90
-5.54%
-2.74
Net Income From Continuing And Discontinued Operation
-101.27
-1377.12%
-6.86
-136.77%
-2.90
-5.54%
-2.74
Net Income Continuous Operations
-101.27
-1377.12%
-6.86
-136.77%
-2.90
-5.54%
-2.74
Normalized Income
-85.73
-1150.43%
-6.86
-136.77%
-2.90
+36.52%
-4.56
Net Income Common Stockholders
-101.27
-1377.12%
-6.86
-136.77%
-2.90
-5.54%
-2.74
Diluted EPS
—
-0.15
-150.00%
-0.06
-3.33%
-0.06
Basic EPS
—
-0.15
-150.00%
-0.06
-3.33%
-0.06
Basic Average Shares
—
47.25
+5.66%
44.72
-5.36%
47.25
Diluted Average Shares
—
47.25
+5.66%
44.72
-5.36%
47.25
Diluted NI Availto Com Stockholders
-101.27
-1377.12%
-6.86
-136.77%
-2.90
-5.54%
-2.74
Depreciation Amortization Depletion Income Statement
3.21
+188.07%
1.11
0.00
-100.00%
2.09
Depreciation And Amortization In Income Statement
3.21
+188.07%
1.11
0.00
-100.00%
2.09
Earnings From Equity Interest
—
—
-0.08
—
Line Item Trend 2025-12-31
Total Assets
30.46
Current Assets
2.82
Cash Cash Equivalents And Short Term Investments
0.04
Cash And Cash Equivalents
0.04
Receivables
1.14
Accounts Receivable
1.14
Gross Accounts Receivable
1.98
Allowance For Doubtful Accounts Receivable
-0.85
Inventory
1.64
Finished Goods
2.07
Prepaid Assets
0.00
Current Deferred Assets
0.00
Other Current Assets
—
Total Non Current Assets
27.64
Net PPE
1.20
Gross PPE
2.47
Accumulated Depreciation
-1.28
Properties
0.00
Machinery Furniture Equipment
0.15
Other Properties
1.56
Leases
0.77
Goodwill And Other Intangible Assets
26.36
Goodwill
14.19
Other Intangible Assets
12.17
Investments And Advances
—
Long Term Equity Investment
—
Non Current Prepaid Assets
0.09
Other Non Current Assets
—
Total Liabilities Net Minority Interest
42.91
Current Liabilities
29.78
Payables And Accrued Expenses
13.06
Payables
11.92
Accounts Payable
11.69
Other Payable
—
Current Accrued Expenses
1.15
Pensionand Other Post Retirement Benefit Plans Current
4.59
Current Debt And Capital Lease Obligation
11.64
Current Debt
11.07
Other Current Borrowings
10.89
Current Capital Lease Obligation
0.57
Current Deferred Liabilities
0.49
Current Deferred Revenue
0.49
Total Non Current Liabilities Net Minority Interest
13.13
Long Term Debt And Capital Lease Obligation
13.13
Long Term Debt
12.60
Long Term Capital Lease Obligation
0.53
Stockholders Equity
-12.45
Common Stock Equity
-12.45
Capital Stock
0.01
Common Stock
0.01
Share Issued
101.31
Ordinary Shares Number
101.31
Treasury Shares Number
0.98
Additional Paid In Capital
98.57
Retained Earnings
-111.03
Total Equity Gross Minority Interest
-12.45
Total Capitalization
0.15
Working Capital
-26.96
Invested Capital
11.22
Total Debt
24.77
Net Debt
23.63
Capital Lease Obligations
1.10
Net Tangible Assets
-38.81
Tangible Book Value
-38.81
Current Notes Payable
—
Duefrom Related Parties Current
0.00
Dueto Related Parties Current
0.23
Interest Payable
0.83
Inventories Adjustments Allowances
-6.42
Line Of Credit
0.18
Non Current Note Receivables
0.00
Other Inventories
5.99
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-10.86
-786.13%
-1.22
-250.86%
-0.35
0.00
Cash Flow From Continuing Operating Activities
-10.86
-786.13%
-1.22
-250.86%
-0.35
0.00
Net Income From Continuing Operations
-101.27
-1377.12%
-6.86
-136.77%
-2.90
-55055.89%
-0.01
Depreciation Amortization Depletion
3.21
+188.07%
1.11
0.00
—
Depreciation
0.16
+134.86%
0.07
0.00
—
Amortization Cash Flow
3.05
+191.51%
1.05
0.00
—
Depreciation And Amortization
3.21
+188.07%
1.11
0.00
—
Amortization Of Intangibles
3.05
+191.51%
1.05
0.00
—
Other Non Cash Items
0.03
—
—
—
Stock Based Compensation
54.79
+4968.38%
1.08
0.00
—
Provisionand Write Offof Assets
5.99
0.00
—
—
Asset Impairment Charge
14.92
+15878.93%
0.09
0.00
—
Operating Gains Losses
2.99
—
—
—
Change In Working Capital
8.48
+153.84%
3.34
+31.24%
2.55
+48405.68%
0.01
Change In Receivables
0.80
+2095.39%
-0.04
0.00
—
Changes In Account Receivables
0.80
+2095.39%
-0.04
0.00
—
Change In Inventory
1.89
+2713.36%
-0.07
0.00
—
Change In Prepaid Assets
0.00
-95.42%
0.01
0.00
—
Change In Payables And Accrued Expense
5.43
+695.80%
0.68
-75.77%
2.82
+53533.43%
0.01
Change In Accrued Expense
3.23
+106.68%
1.56
-12.22%
1.78
0.00
Change In Payable
2.20
+348.87%
-0.88
-185.38%
1.03
+19584.23%
0.01
Change In Account Payable
2.20
+348.87%
-0.88
-185.38%
1.03
+19584.23%
0.01
Change In Other Working Capital
0.32
-90.35%
3.33
+1335.58%
-0.27
—
Change In Other Current Assets
0.00
+100.00%
-0.59
0.00
—
Change In Other Current Liabilities
0.04
+88.97%
0.02
0.00
—
Investing Cash Flow
-0.88
-287.93%
0.47
0.00
—
Cash Flow From Continuing Investing Activities
-0.88
-287.93%
0.47
0.00
—
Capital Expenditure
-0.88
-133.65%
-0.38
—
—
Capital Expenditure Reported
-0.88
-133.65%
-0.38
—
—
Net Business Purchase And Sale
0.00
-100.00%
0.93
0.00
—
Net Intangibles Purchase And Sale
—
-0.38
0.00
—
Purchase Of Intangibles
—
-0.38
0.00
—
Net Other Investing Changes
—
-0.09
—
—
Financing Cash Flow
10.75
+503.00%
1.78
+408.67%
0.35
0.00
Cash Flow From Continuing Financing Activities
10.75
+503.00%
1.78
+408.67%
0.35
0.00
Net Issuance Payments Of Debt
-2.08
-434.85%
0.62
+77.34%
0.35
0.00
Issuance Of Debt
22.67
+2896.64%
0.76
+116.14%
0.35
0.00
Repayment Of Debt
-24.75
-18126.51%
-0.14
0.00
—
Long Term Debt Issuance
2.60
0.00
-100.00%
0.35
—
Long Term Debt Payments
-0.65
0.00
—
—
Net Long Term Debt Issuance
1.95
0.00
-100.00%
0.35
—
Short Term Debt Issuance
20.07
+2553.08%
0.76
0.00
0.00
Short Term Debt Payments
-24.09
-17645.63%
-0.14
0.00
—
Net Short Term Debt Issuance
-4.02
-748.37%
0.62
0.00
0.00
Net Common Stock Issuance
11.37
+113628.40%
0.01
+1900.00%
0.00
0.00
Proceeds From Stock Option Exercised
2.30
0.00
—
—
Net Other Financing Charges
-0.84
-173.04%
1.15
—
—
Changes In Cash
-0.99
-195.99%
1.03
+75191.20%
0.00
—
Beginning Cash Position
1.03
+75291.20%
0.00
0.00
0.00
End Cash Position
0.04
-95.86%
1.03
+75291.20%
0.00
0.00
Free Cash Flow
-11.74
-632.49%
-1.60
-358.93%
-0.35
0.00
Interest Paid Supplemental Data
3.11
+834.60%
0.33
—
—
Income Tax Paid Supplemental Data
0.00
0.00
—
—
Common Stock Issuance
11.37
+113628.40%
0.01
+1900.00%
0.00
0.00
Issuance Of Capital Stock
11.37
+113628.40%
0.01
+1900.00%
0.00
0.00
Sale Of Business
0.00
-100.00%
0.93
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category